New Approval added for Exxelon Patch
Latest FDA approval of Alzheimer’s patch from Novartis gives patients some relief The Exelon Patch from Novartis recently received FDA approval as a high-dose medication for patients with late stage Alzheimer’s disease. Medical experts say the patch is easier to take... READ MORE